Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011
Open Access
- 5 August 2014
- journal article
- research article
- Published by BMJ in Open Heart
- Vol. 1 (1), e000109
- https://doi.org/10.1136/openhrt-2014-000109
Abstract
Objective To characterise the trends in the left ventricular assist device (LVAD) implantation rates and outcomes between 2004 and 2011 in the Medicare population. Since the approval of the HeartMate II in 2008, the use of LVADs has steadily climbed. Given the increase in LVAD use, issues around discharge disposition, post-implant hospitalisations and costs require further understanding. Methods We examined LVAD implantation rates and short-term and long-term outcomes among Medicare fee-for-service beneficiaries hospitalised for LVAD implantation. We also conducted analyses among survivors 1-year post-discharge to examine rehospitalisation rates. Lastly, we reported Centers for Medicare & Medicaid Services (CMS) payments for both index hospitalisation and rehospitalisations 1 year post-discharge. Results A total of 2152 LVAD implantations were performed with numbers increasing from 107 in 2004 to 612 in 2011. The 30-day mortality rate decreased from 52% to 9%, and 1-year mortality rate decreased from 69% to 31%. We observed no change in overall length of stay, but post-procedure length of stay increased. We also found an increase in home discharge dispositions from 26% to 53%. Between 2004 and 2010, the rehospitalisation rate increased and the number of hospital days decreased. The adjusted CMS payment for the index hospitalisation increased from $188 789 to $225 697 over time but decreased for rehospitalisation from $60 647 to $53 630. Conclusions LVAD implantations increased over time. We found decreasing 30-day and 1-year mortality rates and increasing home discharge disposition. The proportion of patients rehospitalised among 1-year survivors remained high with increasing index hospitalisation cost, but decreasing post-implantation costs over time.This publication has 24 references indexed in Scilit:
- Trends in the Use and Outcomes of Ventricular Assist Devices Among Medicare Beneficiaries, 2006 Through 2011Journal of the American College of Cardiology, 2014
- Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation: A Prospective Study Using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support)Journal of the American College of Cardiology, 2011
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceThe New England Journal of Medicine, 2009
- Extended Mechanical Circulatory Support With a Continuous-Flow Rotary Left Ventricular Assist DeviceJournal of the American College of Cardiology, 2009
- Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare BeneficiariesJama-Journal Of The American Medical Association, 2008
- More Accurate Racial and Ethnic Codes for Medicare Administrative Data2008
- Improved Mechanical Reliability of the HeartMate XVE Left Ventricular Assist SystemThe Annals of Thoracic Surgery, 2006
- ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)Journal of the American College of Cardiology, 2005
- HeartMate® VE LVAS design enhancements and its impact on device reliability1European Journal of Cardio-Thoracic Surgery, 2004
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureThe New England Journal of Medicine, 2001